Clomid
Clomid Dragon Pharma — Overview
Clomid Dragon Pharma is clomiphene citrate, a non-steroidal selective estrogen receptor modulator (SERM) available in 50 mg tablets. It is the most widely used oral agent for post-cycle therapy (PCT) after anabolic steroid cycles. Clomiphene works by blocking estrogen receptors in the hypothalamus and pituitary gland, removing the negative feedback that suppresses LH and FSH release. The result is a sharp increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which signals the testes to resume testosterone production.
This page covers the mechanism behind clomiphene's action on the HPG axis, its documented effects on LH, FSH, and testosterone recovery, how it fits into a complete PCT protocol alongside Nolvadex and HCG, and its notable side effect profile including the vision disturbances unique to this compound.
About the Compound: Clomiphene Citrate
Clomiphene citrate is a triphenylethylene compound structurally related to tamoxifen. It is a racemic mixture of two stereoisomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). Enclomiphene is the pharmacologically active SERM component responsible for LH and FSH stimulation. Zuclomiphene has a longer half-life and weak estrogenic partial agonist properties, which contributes to some of clomiphene's mixed activity in non-hypothalamic tissues.
Clomiphene's primary mechanism is competitive antagonism at estrogen receptors in the hypothalamus and anterior pituitary. During and after an AAS cycle, circulating androgens (which aromatize to estrogens) and direct anabolic steroid activity suppress GnRH release from the hypothalamus, collapsing LH and FSH output and shutting down endogenous testosterone production. Clomiphene blocks the estrogen receptors that mediate this suppression. The hypothalamus reads the blocked receptors as an estrogen-deficient state and increases GnRH pulse frequency, which drives LH and FSH release from the pituitary, and LH in turn signals Leydig cells in the testes to resume testosterone synthesis. The testes also require time to regain sensitivity after prolonged suppression, which is why HCG is often used in the weeks before Clomid PCT begins.
What Clomid Does
Clomiphene's effects operate through HPG axis disinhibition. By blocking hypothalamic and pituitary estrogen receptors, it triggers a hormonal cascade that restores the axis suppressed by AAS use:
- LH restoration — within days of starting clomiphene, LH levels rise substantially; LH is the primary signal for Leydig cell testosterone production; the speed of LH recovery is one of clomiphene's clinical advantages over waiting for natural recovery, which in heavily suppressed users can take months or longer
- FSH restoration — rising FSH restores Sertoli cell function and supports spermatogenesis; this is why clomiphene (unlike many other PCT options) also addresses fertility recovery in addition to testosterone normalization; FSH recovery is particularly relevant for users concerned about sperm production after extended AAS use
- Testosterone production — elevated LH drives Leydig cell testosterone synthesis; serum testosterone rises progressively over the PCT period; the rate of recovery depends on the depth of prior suppression, the AAS used, cycle length, and whether testicular atrophy was significant; HCG pre-treatment before PCT substantially improves the speed and completeness of testosterone recovery by restoring Leydig cell volume and sensitivity
- Estrogen management context — clomiphene is not an aromatase inhibitor and does not reduce estrogen production; as testosterone rises during PCT, aromatization also increases, and estrogen levels can rise; this estrogen rebound is why some PCT protocols add a low-dose AI (such as Aromasin) alongside Clomid, particularly in users prone to estrogen-related sides; the AI dose should be modest — estrogen is necessary for libido, mood, and bone health during recovery
- Partial estrogenic activity outside the HPG axis — in hepatic tissue and in some users in breast tissue, clomiphene's zuclomiphene component acts as a partial estrogen agonist; this is a pharmacological distinction from tamoxifen (Nolvadex), which is a more complete estrogen antagonist in breast tissue; users with gynecomastia concerns during PCT may prefer or add Nolvadex for stronger breast tissue protection
Who It's For
- AAS users completing a steroid cycle — clomiphene is the standard SERM for HPG axis recovery after suppressive AAS cycles; it is appropriate after any cycle involving testosterone, nandrolones, Dianabol, Trenbolone, or other suppressive compounds; more suppressive or longer cycles (12+ weeks, multiple compounds) warrant longer PCT durations and often combination with Nolvadex and HCG
- Users prioritizing both testosterone and fertility recovery — because clomiphene raises both LH and FSH, it is the preferred SERM when sperm production recovery is a priority; Nolvadex raises LH but has weaker effects on FSH; clomiphene's FSH-elevating activity makes it the better choice for users who are planning for fertility after a cycle
- Stacking with Nolvadex for stronger recovery — some protocols combine Clomid and Nolvadex at reduced doses of each; the combination produces stronger LH and FSH stimulation than either alone and is commonly used after heavier cycles; typical combination dosing: Clomid 25 mg/day + Nolvadex 20 mg/day for 4–6 weeks
- Men with secondary hypogonadism — clomiphene has documented off-label use in men with low testosterone caused by insufficient LH/FSH drive rather than primary testicular failure; it raises endogenous testosterone without suppressing the axis, making it an alternative to exogenous testosterone therapy for certain presentations
Context & Related Products
A complete PCT protocol typically involves two to three agents targeting different aspects of axis recovery. Clomid handles the central HPG signal; HCG handles testicular priming beforehand; an AI handles the estrogen rebound during recovery:
| Product | Class / Role | How It Fits With Clomid |
|---|---|---|
| Clomid Dragon Pharma (this product) | SERM / HPG stimulant | Core PCT agent; blocks hypothalamic estrogen receptors to drive LH and FSH output; starts after HCG phase ends and continues for 4–6 weeks |
| Nolvadex Dragon Pharma | SERM / HPG stimulant | Alternative or combination SERM; stronger breast tissue antagonist than clomiphene; fewer vision side effects; commonly combined with Clomid at reduced doses for enhanced LH/FSH stimulation after heavier cycles |
| HCG 5000 IU Dragon Pharma | Gonadotropin / testicular primer | Used in the 2–3 weeks before Clomid PCT begins; mimics LH at the testicular level to restore Leydig cell volume and intratesticular testosterone; significantly improves the speed and completeness of testosterone recovery when Clomid PCT follows; typically 500–1000 IU EOD |
| HCG 2500 IU Dragon Pharma | Gonadotropin / testicular primer | Lower-dose HCG vial for the same pre-PCT testicular priming protocol; convenient for users calculating smaller per-injection doses or shorter HCG phases |
| Aromasin Dragon Pharma | Aromatase inhibitor (suicidal AI) | Manages estrogen rebound during PCT as testosterone rises; low-dose Aromasin (12.5 mg EOD) can be added to Clomid PCT for users prone to estrogen-related symptoms; suicidal AI is preferred over reversible AIs during PCT because it carries less risk of rebound after discontinuation |
| Enclomiphene Dragon Pharma | Pure-isomer SERM | Enclomiphene is the active trans-isomer of clomiphene without the zuclomiphene component; raises LH and FSH similarly to Clomid but with a cleaner side effect profile and significantly fewer visual disturbances; an option for users sensitive to clomiphene's ocular side effects |
Side Effects & Management
Clomiphene's most distinctive side effect — visual disturbances — sets it apart from other SERMs and is the main practical reason some users prefer Nolvadex or enclomiphene. The remaining side effects are shared broadly with estrogen receptor modulators.
| What May Occur | Background | How to Handle It |
|---|---|---|
| Visual disturbances | The most clinically notable side effect specific to clomiphene; presents as blurred vision, floaters, light sensitivity (photophobia), or visual after-images; caused by clomiphene's estrogen receptor activity in retinal cells rather than the central HPG antagonism; the zuclomiphene isomer with its longer half-life is believed to be the primary contributor; in most cases fully reversible on discontinuation, but rare cases of persistent visual changes have been reported | Discontinue immediately if visual symptoms appear and do not resume; switching to Nolvadex or enclomiphene avoids this side effect; do not push through visual symptoms hoping they resolve on their own |
| Mood changes and irritability | Estrogen receptor modulation in brain tissue affects serotonin and other neurotransmitter systems; some users experience irritability, emotional lability, or low mood during clomiphene use; more common at higher doses (100 mg/day) than at standard PCT doses of 25–50 mg/day; the effect typically resolves when the compound is discontinued | Keep dosing at the lowest effective level (25 mg/day is often sufficient for mild-to-moderate suppression); if mood effects are significant, consider switching to Nolvadex which tends to have a more neutral mood profile |
| Hot flashes | Estrogen receptor blockade in the hypothalamic thermoregulatory centers causes vasomotor instability; hot flashes are common and are the same mechanism responsible for clomiphene's use in female fertility; typically transient and mild in men at PCT doses | Usually self-limiting and not a reason to discontinue; no specific intervention required; generally decrease in frequency as the body adjusts after the first week or two of use |
| Headache | Mild headaches reported by some users, particularly in the first days of use; likely related to acute changes in gonadotropin levels and associated hormonal shifts; dose-dependent | Usually resolves without intervention; staying well-hydrated on the days of dosing helps; if persistent and severe, reduce dose and reassess |
| Gynecomastia (low risk) | Clomiphene's zuclomiphene component has partial estrogenic agonist activity in breast tissue, which contrasts with tamoxifen's more complete antagonism there; at standard PCT doses clomiphene is generally protective against gynecomastia, but users with pre-existing gynecomastia sensitivity or high baseline estrogen during PCT have occasionally reported worsening | Users with gynecomastia history or concern should consider adding Nolvadex alongside Clomid or substituting it entirely; Nolvadex provides stronger and more reliable breast tissue estrogen antagonism |
References
| Source | Topic | Link |
|---|---|---|
| NCBI Bookshelf / StatPearls | Clomiphene citrate pharmacology — SERM mechanism, hypothalamic estrogen receptor modulation, LH and FSH stimulation, testosterone increase, dosing, pharmacokinetics, and clinical use context | StatPearls: Clomiphene ↗ |
| PubMed / Systematic Review | Clomiphene and enclomiphene for male hypogonadism — testosterone, LH, and FSH response in randomized controlled trials; comparison with placebo and testosterone gel | Hohl et al., 2025 ↗ |
| PubMed / Fertility and Sterility | Clomiphene visual side effects — visual disturbances during clomiphene citrate use, ophthalmologic findings, reversibility, monitoring, and clinical safety recommendations | Racette et al., 2010 ↗ |
What is Clomid?
Clomid (Clomiphene Citrate) is an oral SERM for post-cycle therapy and hormone recovery; see What is Clomiphene Citrate. It restores testosterone—consult professionals for safe use.
How long does Clomid take to work?
Clomid boosts testosterone in 1-2 weeks, with full HPTA recovery in 4-6 weeks; see Results timeline. Monitor with bloodwork for optimal results.
How to take Clomid?
Take 50-100 mg daily, tapering over 4-6 weeks post-cycle; see How to Use. Align with steroid clearance—consult for personalized plans.
What is Clomid used for?
Clomid is used for PCT to restore testosterone and prevent estrogenic effects; see Key Benefits. Ideal for bodybuilders—use with professional oversight.
How long does Clomid stay in your system?
With a 5-7 day half-life, Clomid is detectable for 2-4 weeks; see Mechanism of Action. Plan PCT accordingly—consult professionals for guidance.
What are the main benefits of Clomid?
Commonly discussed benefits include support for natural testosterone production, improved hormonal balance, and stimulation of LH and FSH levels.
Can Clomid help support natural testosterone levels?
Clomid is widely recognized for its ability to stimulate the body's own testosterone production by encouraging natural hormonal pathways.
How is Clomid different from other hormone-support compounds?
Unlike aromatase inhibitors that reduce estrogen production, Clomid works by modulating estrogen receptors, helping stimulate the body's natural hormone production processes.
Related Products
